Pharmacological characterisation of anti-inflammatory compounds in acute and chronic mouse models of cigarette smoke-induced inflammation
<p>Abstract</p> <p>Background</p> <p>Candidate compounds being developed to treat chronic obstructive pulmonary disease are typically assessed using either acute or chronic mouse smoking models; however, in both systems compounds have almost always been administered pro...
Main Authors: | Mok Joanie, Pearce William, Kinnear Gillian, Morris Abigail, Wan Wing-Yan, Wyss Daniel, Stevenson Christopher S |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-09-01
|
Series: | Respiratory Research |
Online Access: | http://respiratory-research.com/content/11/1/126 |
Similar Items
-
Pharmacological Treatment for Pregnant Women who Smoke Cigarettes
by: BC Chan, et al.
Published: (2003-09-01) -
Cigarette smoke and nasal inflammation : an in vitro study
by: Worley, George Anthony
Published: (2005) -
Paeonol Attenuates Cigarette Smoke-Induced Lung Inflammation by Inhibiting ROS-Sensitive Inflammatory Signaling
by: Meng-Han Liu, et al.
Published: (2014-01-01) -
Macrophage Depletion Protects against Cigarette Smoke-Induced Inflammatory Response in the Mouse Colon and Lung
by: Dahae Lim, et al.
Published: (2018-02-01) -
The role of cigarette smoke-induced epigenetic alterations in inflammation
by: Dandan Zong, et al.
Published: (2019-11-01)